Empirical Wealth Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
Empirical Wealth Management's CPRX Position: Q3 2026 in Review
Empirical Wealth Management sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 73,041 shares — an estimated $2.3M sold.
Empirical Wealth Management first reported a position in CPRX in Q4 2021 and held it in 6 quarters. The position peaked at $2.3M in Q2 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- Empirical Wealth Management reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Empirical Wealth Management sold 73,041 Catalyst Pharmaceutical shares in Q3 2026, an estimated $2.3M.
- Empirical Wealth Management first reported a position in Catalyst Pharmaceutical in Q4 2021 and held it in 6 quarters.
- Empirical Wealth Management's Catalyst Pharmaceutical position peaked at $2.3M in Q2 2026.
- 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.